We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nitric Oxide Metabolism Linked to Sepsis

By Biotechdaily staff writers
Posted on 23 Mar 2005
Researchers seeking new ways to treat inflammatory diseases have found that the anti-inflammatory enzyme endothelial nitric oxide synthase (eNOS) plays a second, pro-inflammatory role by facilitating expression of inducible nitric oxide synthase (iNOS), which has been linked to the development of symptoms of septic shock.

Investigators at University College (London, UK) worked with a line of mice that had been genetically engineered to lack the gene for eNOS. More...
These animals displayed a marked reduction in iNOS production in response to bacterial endotoxin as compared to normal control mice. The experimental animals had lower plasma levels of other forms of nitric oxide synthase and fewer incidences of mortality after exposure to bacterial LPS (lipopolysaccharide) than normal mice. These findings were published in the March 18, 2005, issue of the Journal of Biological Chemistry.


"In sepsis, a systemic bacterial infection, the body expresses iNOS, which generates relatively high concentrations of nitric oxide,” explained senior author Dr. Adrian Hobbs, a researcher at University College. "This aids host defense by killing the invading organism, but in excessive quantities starts to lead to host damage. In sepsis, this is manifested predominantly as a profound hypotension, inadequate tissue perfusion, and organ failure. This often results in death. The identification of a pro-inflammatory role for eNOS-derived nitric oxide may provide the stimulus for further research in this area and thereby identify novel targets for treatment of inflammatory diseases.”



Related Links:
University College

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.